GRAIL
Latest round
- Series D
Last raised
- May 2020
Total raised
- $1.9B
Investors
- 25
About GRAIL
Founded in 2016 and based in California, US, GRAIL, Inc. develops a blood screening test that uses data sequencing on the genomic and molecular biology of tumors for the early detection of cancer to decrease mortality. The company was founded by Alex Aravanis, Jeff Huber, and Mostafa Ronaghi. Mr. Hans Bishop serves as the CEO of GRAIL, Inc. as of 2021. In May 2020, GRAIL, Inc. In September 2020, Illumina, Inc. acquired GRAIL, Inc. for USD 8 billion. The company develops a pan-cancer screening test designed to detect cancers at an early stage. It measures circulating nucleic acids in blood using high-intensity sequencing and population-scale clinical trials. Through its technology, the company develops its own product, Galleri, a multi-cancer early detection blood test. GRAIL is also working on technologies to assist doctors in diagnosing cancer more quickly, as well as blood-based detection for minimal residual disease and other post-diagnostic applications. The company's revenue is generated by the sales of its pan-cancer screening test for industrial use.
Who invested in GRAIL
25 investors across 7 rounds
See all investors in GRAIL
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
May 7, 2020
Amount
$263M
Investors
Series C
May 16, 2018
Amount
$300M
Investors
Series B
Jan 11, 2018
Amount
$3M
Investors
Series B
Nov 22, 2017
Amount
$238M
Investors
Series B
Apr 26, 2017
Amount
$59M
Investors
Series B
Feb 28, 2017
Amount
$914M
Investors
Series A
Jan 10, 2016
Amount
$120M
Investors
Questions about GRAIL
Who invested in GRAIL?
GRAIL has 25 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GRAIL raised?
GRAIL has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did GRAIL last raise money?
GRAIL's most recent round on record is a Series D, in May 2020.
What does GRAIL do?
Founded in 2016 and based in California, US, GRAIL, Inc.
Where is GRAIL headquartered?
GRAIL is headquartered in Menlo Park, US.
Which VCs invest in companies like GRAIL?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at GRAIL's stage. Their profiles are linked below.
VCs backing healthcare startups at Series D
Raising like GRAIL? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.